Ceftriaxone induced neurotoxicity: a word of caution for elderly and patients with renal impairment
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251348Keywords:
Ceftriaxone, Neurotoxicity, Letter to the EditorAbstract
Ceftriaxone is a third-generation cephalosporin commonly used in inpatient settings and is associated with both hepatic and renal excretion. The cephalosporin group, particularly the fourth generation, including cefepime, has been commonly associated with encephalopathy, but recent literature has also suggested an increasing trend of encephalopathy related to ceftriaxone.
Metrics
References
Hagiya H, Miyawaki K, Yamamoto N. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation. Intern Med. 2017;56(22):3103–7. DOI: https://doi.org/10.2169/internalmedicine.8774-16
Safadi S, Mao M, Dillon JJ. Ceftriaxone-Induced Acute Encephalopathy in a Peritoneal Dialysis Patient. Case Rep Nephrol. 2014;2(1):108185. DOI: https://doi.org/10.1155/2014/108185
Zarauskas A, Rodrigues B, Alvarez V. Ceftriaxone-induced encephalopathy in a patient with a normal renal function. BMJ Case Rep CP. 2024;17(1):256934. DOI: https://doi.org/10.1136/bcr-2023-256934
Takano T, Kaburagi M, Morikubo S. Ceftriaxone-Related Encephalopathy in a Patient With End-Stage Renal Disease and High Ceftriaxone Concentrations in Cerebrospinal Fluid and Plasma: A Case Report. Cureus. 2016;15(10):46401.
Nishioka H, Cho Y, Irie K. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid. Int J Infect Dis. 2022;116:223–5. DOI: https://doi.org/10.1016/j.ijid.2022.01.023